Which Albuterol formulation can be used via a nebulizer for patients 2 years and older?

Albuterol nebulizer solution is specifically formulated for administration via nebulization, making it suitable for patients aged 2 years and older. This formulation allows for direct delivery of the medication to the lungs, which provides effective relief from bronchospasm associated with conditions like asthma or COPD. Nebulizers convert the solution into a mist that can be easily inhaled, providing a method of treatment that can be particularly beneficial for younger patients who may struggle with other delivery methods such as inhalers.

Other formulations, such as syrup and tablets, are not intended for nebulization. These methods may take longer to exhibit their effects and may not provide the same level of rapid relief as the nebulizer solution. Xopenex HFA, while another bronchodilator, is an aerosolized metered-dose inhaler and not a nebulizer solution, making it unsuitable for nebulization regardless of the patient's age. Therefore, the nebulizer solution is the appropriate choice for effective treatment in the specified age group.